Author:
Bai Dong-lu,Chen Wei-zhou,Bo Yun-xin,Dong Yue-li,Kang Ai-li,Sun Wei-kang,Wang Wei,Hu Zhong-liang,Wang Yi-ping
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference20 articles.
1. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781–8.
2. Nattel S, Carlsson L . Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 2006; 5: 1034–49.
3. Walker MJA, So PPS . Anti-arrhythmics, In: Comprehensive Medicinal Chemistry II, Vol. 6 (Williams, M Ed). Amsterdam: Elsevier; 2007. p 729–62.
4. Li LQ, Qu ZX, Wang ZM, Zeng YL, Ding GS, Hu GJ, et al. Studies on a new antiarrhythmic drug changrolin — 4-(3′, 5′- bis(N-pyrrolidinylmethyl)-4′-hydroyanilino)quinazoline. Sci Sin 1979; 22: 1220–8.
5. Changrolin Coordination Research Group. Clinical observation on changrolin, an antiarrhythmic drug. Nat Med J Chin 1978; 58: 84–6.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献